Aspiriant LLC’s Schwab Fundamental US Large Company Index ETF FNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$291K Buy
9,250
+1,051
+13% +$33.7K 0.01% 325
2026
Q2
$255K Hold
8,199
– – 0.01% 342
2026
Q1
$228K Hold
8,199
– – 0.01% 316
2025
Q4
$223K Hold
8,199
– – 0.01% 309
2025
Q3
$216K Sell
8,199
-783
-9% -$19.9K 0.01% 288
2025
Q2
$220K Hold
8,982
– – 0.01% 293
2025
Q1
$212K Hold
8,982
– – 0.01% 281
2024
Q4
$213K Hold
8,982
– – 0.01% 278
2024
Q3
$215K Buy
+8,982
New +$207K 0.01% 272
2018
Q4
– Sell
-18,525
Closed -$245K – 235
2018
Q3
$245K Hold
18,525
– – 0.02% 212
2018
Q2
$231K Sell
18,525
-10,860
-37% -$135K 0.02% 227
2018
Q1
$356K Buy
+29,385
New +$370K 0.03% 176

Other funds holding FNDX

Aspiriant LLC's FNDX Position: Q3 2026 in Review

Aspiriant LLC increased its Schwab Fundamental US Large Company Index ETF (FNDX) stake by 13% in Q3 2026, buying an estimated $33.7K and bringing the position to 9,250 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #325.

Aspiriant LLC first reported a position in FNDX in Q1 2018 and has held it in 12 quarters since. The position peaked at $356K in Q1 2018. 538 funds tracked by Wall St. Rank hold FNDX as of Q3 2026.

  • Aspiriant LLC held 9,250 shares of Schwab Fundamental US Large Company Index ETF worth $291K as of Q3 2026.
  • Aspiriant LLC bought 1,051 Schwab Fundamental US Large Company Index ETF shares in Q3 2026, an estimated $33.7K.
  • Schwab Fundamental US Large Company Index ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #325 holding.
  • Aspiriant LLC first reported a position in Schwab Fundamental US Large Company Index ETF in Q1 2018 and has held it in 12 quarters since.
  • Aspiriant LLC's Schwab Fundamental US Large Company Index ETF position peaked at $356K in Q1 2018.
  • 538 funds tracked by Wall St. Rank held Schwab Fundamental US Large Company Index ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.